Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Lambert

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Journal of Neuropathology and Experimental Neurology|March 1, 1978
Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravisK Sahashi, A G Engel, J M Linstrom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravisV A Lennon, E H Lambert, K R Leiby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1987
Myasthenogenicity of human acetylcholine receptor synthetic alpha-subunit peptide 125-147 does not require intramolecular disulfide cyclizationD J McCormick, G E Griesmann, Z X Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodiesV A Lennon, D J McCormick, E H Lambert, et al.
Mayo Clinic Proceedings|April 1, 1982
Prednisone-responsive hereditary motor and sensory neuropathyP J Dyck, C J Swanson, P A Low, et al.
Mayo Clinic Proceedings|November 1, 1975
Uremic neuropathy. III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatmentP J Dyck, W J Johnson, R A Nelson, et al.
The Journal of Experimental Medicine|September 1, 1976
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodiesJ M Lindstrom, A G Engel, M E Seybold, et al.
Neurology|February 1, 1979
Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptorA G Engel, H Sakakibara, K Sahashi, et al.
Cancer Research|September 1, 1988
Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosineH J De Aizpurua, E H Lambert, G E Griesmann, et al.
Journal of Neuropathology and Experimental Neurology|May 1, 1977
Lead neuropathy. 1) Morphometry, nerve conduction, and choline acetyltransferase transport: new finding of endoneurial edema associated with segmental demyelinationA Ohnishi, K Schilling, W S Brimijoin, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Journal of Neuropathology and Experimental Neurology|March 1, 1978
Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravisK Sahashi, A G Engel, J M Linstrom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravisV A Lennon, E H Lambert, K R Leiby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1987
Myasthenogenicity of human acetylcholine receptor synthetic alpha-subunit peptide 125-147 does not require intramolecular disulfide cyclizationD J McCormick, G E Griesmann, Z X Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodiesV A Lennon, D J McCormick, E H Lambert, et al.
Mayo Clinic Proceedings|April 1, 1982
Prednisone-responsive hereditary motor and sensory neuropathyP J Dyck, C J Swanson, P A Low, et al.
Mayo Clinic Proceedings|November 1, 1975
Uremic neuropathy. III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatmentP J Dyck, W J Johnson, R A Nelson, et al.
The Journal of Experimental Medicine|September 1, 1976
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodiesJ M Lindstrom, A G Engel, M E Seybold, et al.
Neurology|February 1, 1979
Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptorA G Engel, H Sakakibara, K Sahashi, et al.
Cancer Research|September 1, 1988
Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosineH J De Aizpurua, E H Lambert, G E Griesmann, et al.
Journal of Neuropathology and Experimental Neurology|May 1, 1977
Lead neuropathy. 1) Morphometry, nerve conduction, and choline acetyltransferase transport: new finding of endoneurial edema associated with segmental demyelinationA Ohnishi, K Schilling, W S Brimijoin, et al.
Pageof 11